The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene

Japanese Journal of Cancer Research

Volumn 87, Issue 1, 1996, Pages 18-24

  Kiyohara, Chikako ^a   Hirohata, Tomio ^a   Inutsuka, Satoru ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Aryl hydrocarbon hydroxylase; CYP1A1 gene; Ile Val polymorphism; MspI polymorphism

Indexed keywords

3 METHYLCHOLANTHRENE; CYTOCHROME P450; UNSPECIFIC MONOOXYGENASE;

ADULT; ALLELE; ARTICLE; CANCER PREVENTION; ENZYME INDUCTION; EXON; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; JAPAN; LUNG CANCER; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING;

EID: 0030028660     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00194.x     Document Type: Article

References (34)

1. Kouri, R. E., Salero, R. E. and Whitmire, C. E. Relationships between aryl hydrocarbon hydroxylase inducibility and susceptibility to chemically induced subcutaneous sarcoma in various strains of mice. J. Natl. Cancer Inst., 50, 363-368 (1973).
2. Kouri, R. E., Ratire, H. and Whitmire, C. E. Genetic control of susceptibility to 3-methylcholanthrene-induced subcutaneous sarcoma. Int. J. Cancer, 13, 714-720 (1974).
3. Kellermann, G., Shaw, C. R. and Luyten-Kellermann, M. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med., 289, 934-937 (1973).
4. Kellermann, G., Luyten-Kellermann, M. and Shaw, C. R. Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am. J. Hum. Genet., 25, 327-331 (1973).
5. Guirgis, H. A., Lynch, H. T., Mate, T., Haris, R. E. and Well, I. Aryl hydrocarbon hydroxylase inducibility in lymphocytes from lung cancer patients and normal controls. Oncology, 33, 105-109 (1976).
6. Trell, E., Kordgaard, R., Hood, B., Kittzing, O., Norden, G. and Simonsson, B. G. Aryl hydrocarbon hydroxylase inducibility and laryngeal carcinomas. Lancet, ii, 140 (1976).
7. Paigen, B., Minowada, J., Gurtoo, H. L., Paigen, K., Parker, N. B., Ward, E., Hayner, N. T., Bross, I .D. J., Boch, F. and Vincent, R. Distribution of aryl hydrocarbon hydroxylase inducibility in cultured human lymphocytes. Cancer Res., 37, 1829-1837 (1977).
8. Ward, E., Paigen, B., Steenland, K., Vincent, R., Minowada, J., Gurtoo, H. L., Sartori, P. and Havens, M. B. Aryl hydrocarbon hydroxylase in persons with lung or laryngeal cancer. Int. J. Cancer, 22, 384-389 (1978).
9. Lieberman, J. Aryl hydrocarbon hydroxylase in bronchogenic carcinoma. N. Engl. J. Med., 298, 686-687 (1978).
10. Kärki, N. T., Pokela, R., Nuutinen, L. and Pelkonen, O. Aryl hydrocarbon hydroxylase in lymphocytes and lung tissue from lung cancer patients and controls. Int. J. Cancer, 39, 565-570 (1987).
11. Atlas, S. A., Vesell, E. S. and Nebert, D. W. Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes. Cancer Res., 36, 4619-4630 (1976).
12. Paigen, B., Gurtoo, H. L., Minowada, J., Ward, E., Houten, J., Paigen, K., Reilly, A. and Vincent, R. Genetics of aryl hydrocarbon hydroxylase in the human population and its relationship to lung cancer. In "Polycyclic Hydrocarbons and Cancer," ed. H. V. Gelboin and P. O. P. Ts'o, Vol. 2, pp. 391-405 (1978). Academic Press, New York.
13. Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N. and Watanabe, J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett., 263, 131-133 (1990).
14. Hayashi, S., Watanabe, J., Nakachi, K. and Kawajiri, K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J. Biochem., 110, 407-411 (1991).
15. Kiyohara, C., Mohri, N., Hirohata, T., Haraguchi, K. and Masuda, Y. In vitro effect of methylsulfonyl polychlorinated biphenyls and 7,8-benzoflavone on aryl hydrocarbon hydroxylase activity in human lymphoblastoid cells. Pharmacol. Toxicol., 66, 273-276 (1990).
16. Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullius, K. B. and Erlich, H. A. Primer-directed enzymatic amplification of DNA sequencing with a thermostable DNA polymerase. Science, 239, 487-491 (1988).
17. Nakachi, K., Imai, K., Hayashi, S.-I., Watanabe, J. and Kawajiri, K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res., 51, 5177-5180 (1991).
18. SAS Institute Inc. "SAS User's Guide: Statistics, Version 5 Edition" (1985). SAS Institute Inc., Cary, NC.
19. 1450 (CYP1A1) gene. Int. J. Biochem., 21, 234-252 (1989).
20. Nagayama, J., Kiyohara, C., Masuda, Y. and Kuratsune, M. Aryl hydrocarbon hydroxylase activity in human lymphoblastoid cells by polychlorinated dibenzofuran isomers and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch. Toxicol., 56, 230-235 (1985).
21. Nebert, D. W., Benedict, W. F. and Kouri, R. E. Aromatic hydrocarbon produced tumorigenesis and the genetic difference in aryl hydrocarbon hydroxylase. In "Chemical Carcinogenesis," ed. P. O. P. Ts'o and J. A. DiPaolo, Part A, pp. 271-288 (1974). Marcel Decker Inc., New York.
22. 1-450 gene linked to the MPI locus on chromosome 15. Nucleic Acids Res., 14, 4376 (1986).
23. Haugen, A., Willey, J., Borresen, A. L. and Tefre, T. PstI polymorphism at the human P1450 gene on chromosome 15. Nucleic Acids Res., 18, 3114 (1990).
24. Bale, A. E., Nebert, D. W. and McBride, O. W. Subchromosomal localization of the dioxin-inducible P1450 locus (CYP1) and description of two RFLPs detected with 3′-P1450 cDNA probe. Cytogenet. Cell Genet., 46, 574-575 (1987).
25. Spurr, N. K., Gough, A .C., Stevenson, K. and Wolf, C. R. Msp-I polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res., 15, 5901 (1987).
26. Tefre, T., Ryberg, D., Haugen, A., Nebert, D. W., Skaung, V., Brøgger, A. and Børresen, A.-L. Human CYP1A1 (cytochrome P1 450) gene: lack of association between the MspI restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics, 1, 20-58 (1991).
27. Shields, P. G., Sugimura, H., Caporaso, N. E., Petruzzelli, S. F., Bowman, E. D., Trump, B. F., Weston, A. and Harris, C. C. Polycyclic hydrocarbon-DNA adducts and the CYP1A1 RFLP. Environ. Health Perspect., 98, 191-194 (1992).
28. Hivronen, A., Husgafvel-Pursianin, K., Karjalanen, A., Anttila, S. and Vainio, H. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol. Biomarkers Prev., 1, 485-489 (1992).
29. Raben, M., Walach, N., Galili, U. and Schlesinger, M. The effect of radiation therapy on lymphocytes subpopulations in cancer patients. Cancer, 37, 3771-3773 (1976).
30. Prasad, R., Prasad, S., Harrell, J. E., Thornby, J., Liem, J. H., Hudgins, P. H. and Guinn, G. A. Aryl hydrocarbon hydroxylase inducibility and lymphoblast formation in lung cancer patients. Int. J. Cancer, 23, 316-320 (1979).
31. Jett, J. R., Moses, H. L., Branum, E. L., Taylor, W. F. and Fontana, R. S. Benzo(a)pyrene metabolism and blast transformation in peripheral blood mononuclear cells from smoking and nonsmoking population and lung cancer patients. Cancer, 41, 192-200 (1978).
32. Nebert, D. W. and Jensen, N. M. The Ah locus: genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450-mediated monooxygenases. CRC Crit. Rev. Biochem., 6, 401-437 (1979).
33. Alfred, L. J. and Wojdani, A. Effects of 3-methylcholanthrene and benzanthracene on blastogenesis and aryl hydrocarbon hydroxylase induction in splenic lymphocytes from three inbred strains of mice. Int. J. Immunopharmacol., 5, 123-129 (1983).
34. Jaiswal, A. K., Gonzallez, F. J. and Nebert, D. W. Human P1-450 gene sequence and correlation of mRNA with genetic differences in benzo(a)pyrene metabolism. Nucleic Acids Res., 13, 4503-4520 (1985).